• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    China Natural Resources Appoints 20-year Pharmaceutical Executive Dr. Peng Wenlie as Vice President

    3/23/21 8:30:00 AM ET
    $CHNR
    Precious Metals
    Basic Materials
    Get the next $CHNR alert in real time by email

    HONG KONG, March 23, 2021 /PRNewswire/ -- China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") announced today the appointment of pharmaceutical industry executive Peng Wenlie as Vice President, effective March 22, 2021.  Dr. Peng, who brings more than 20 years of experience working in the industry, will report directly to the Company's Chairman, Mr. Wong Wah On Edward.  He will be responsible for evaluating the Company's investment opportunities in the healthcare, biomedicine, and related markets.

    Mr. Wong Wah On Edward, Chairman of the Company, commented, "We are excited to announce the addition of Dr. Peng Wenlie as Vice President.  He shares our positive outlook for the extensive opportunities to diversify our business and expand our addressable market into the large, established Chinese healthcare market.  We are actively conducting due diligence as we explore compelling business opportunities in the healthcare and other non-natural resources sectors.  Adding Dr. Peng will immediately bolster our capacity and deep knowledge base.  We look forward to his meaningful contributions, unique perspective and helpful guidance as we further refine our strategy and prioritize potentially attractive opportunities to accelerate our future revenue growth and profitability."

    Dr. Peng has been engaged in the development of natural medicines and investment consulting for more than 20 years.  He currently serves as Chairman of the Board of Shanghai Onway Environmental Development Co., Ltd., as director of Guangxi Huaxia Herbal Medicine Co. Ltd., and as director of Guangxi Huaxia Herbal Medicine Sales Co. Ltd. He previously served as Director of the Biomedicine Investment Department of Feishang Enterprise Group Company Ltd. ("Feishang"). While at Feishang, Dr. Peng led the selection of target companies for investment in the biomedical space, conducting due diligence and appraising risks and returns as part of the investment decisions. Earlier in his career, Dr. Peng was a professor in the Life Sciences School of Sun Yat-sen University. He was awarded a Doctor of Science degree from Sun Yat-sen University in 1999 and a Master of Science degree in 1996.

    About China Natural Resources:

    China Natural Resources, Inc., a British Virgin Islands corporation, through its operating subsidiaries in the People's Republic of China (the "PRC"), is currently engaged in the acquisition and exploitation of mining rights in Inner Mongolia, including preliminary exploration for lead, silver and other nonferrous metal, and is actively exploring business opportunities in the healthcare and other non-natural resources sectors.

    Forward-Looking Statements:

    This press release includes forward-looking statements within the meaning of the U.S. federal securities laws. These statements include, without limitation, statements regarding the intent, belief and current expectations of the Company, its directors or its officers with respect to: the potential presented by the healthcare sector in the PRC; the impact on the Company's financial position of an investment in the healthcare sector of the PRC; and its ability to locate and execute on strategic opportunities. Forward-looking statements are not a guarantee of future performance and involve risks and uncertainties, and actual results may differ materially from those in the forward-looking statement as a result of various factors. Among the risks and uncertainties that could cause the Company's actual results to differ from its forward-looking statements are: the potential lack of appetite for the Company's current holdings as consideration for a transaction in the healthcare sector; possible downturns in the healthcare sector in the PRC or other sectors that the Company may invest in; the results of the next assessment by the Staff of the Nasdaq Listing Qualifications department of the Company's compliance with the Nasdaq Listing Rules; uncertainties related to governmental, economic and political circumstances in the PRC; uncertainties related to metal price volatility; uncertainties related to the Company's ability to fund operations; uncertainties related to possible future increases in operating expenses, including costs of labor and materials; uncertainties related to the impact of the COVID-19 pandemic; uncertainties related to the political situation between the PRC and the United States, and potential negative impacts on companies with operations in the PRC that are listed on exchanges in the United States; and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. When, in any forward-looking statement, the Company, or its management, expresses an expectation or belief as to future results, that expectation or belief is expressed in good faith and is believed to have a reasonable basis, but there can be no assurance that the stated expectation or belief will result or be achieved or accomplished. Except as required by law, the Company undertakes no obligation to update any forward-looking statements.

    For more information please contact:

    David Pasquale
    Global IR Partners
    New York Office Phone: +1-914-337-8801
    [email protected]

    SOURCE China Natural Resources, Inc.

    Get the next $CHNR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHNR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CHNR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • China Natural Resources Announces Effective Date of Share Combination

      HONG KONG, June 10, 2025 /PRNewswire/ -- China Natural Resources, Inc. (NASDAQ:CHNR), a British Virgin Islands ("BVI") company (the "Company") today announced that it will implement the combination (the "Combination") of issued and outstanding common shares, without par value, of the Company. The Company's common shares will begin trading on a post-Combination basis at market open on June 13, 2025. Upon the effectiveness of the share combination, every eight issued and outstanding common shares will automatically be converted into one issued and outstanding common share. No fractional shares will be issued as a result of the share combination. Instead, any fractional shares that would have

      6/10/25 4:10:00 PM ET
      $CHNR
      Precious Metals
      Basic Materials
    • China Natural Resources Announces 8-to-1 Share Combination

      HONG KONG, May 27, 2025 /PRNewswire/ -- China Natural Resources, Inc. (NASDAQ:CHNR), a British Virgin Islands ("BVI") company (the "Company") today announced that the board of directors of the Company has approved an eight-to-one share combination of issued and outstanding common shares, without par value, of the Company. No shareholders' approval of the share combination is required pursuant to BVI law. The share combination is expected to be effective at the market opening on June 12, 2025, at which time the Company's common shares will begin trading on the Nasdaq Capital Market on a combination-adjusted basis. The Company's common shares will continue to trade under the symbol "CHNR" but

      5/27/25 4:15:00 PM ET
      $CHNR
      Precious Metals
      Basic Materials
    • CHINA NATURAL RESOURCES REPORTS FULL YEAR 2024 RESULTS

      HONG KONG, May 15, 2025 /PRNewswire/ -- China Natural Resources Inc. (NASDAQ:CHNR) (the "Company") today announced its results of operations for the year ended December 31, 2024. For the convenience of the reader, amounts in Chinese Yuan ("CNY") have been translated into United States dollars ("US$") at the rate of US$1.00 = CNY7.2980 as quoted by www.ofx.com on December 31, 2024, except as otherwise disclosed. Mr. Wong Wah On Edward, Chairman of the Company, commented, "We are prudently investing in our exploration activities as we continue to evaluate the further value from the Wulatehouqi Moruogu Tong Mine. The intensifying trade frictions and geopolitical tensions significantly and adve

      5/15/25 4:15:00 PM ET
      $CHNR
      Precious Metals
      Basic Materials

    $CHNR
    SEC Filings

    See more
    • SEC Form 6-K filed by China Natural Resources Inc.

      6-K - CHINA NATURAL RESOURCES INC (0000793628) (Filer)

      6/10/25 4:15:02 PM ET
      $CHNR
      Precious Metals
      Basic Materials
    • SEC Form 6-K filed by China Natural Resources Inc.

      6-K - CHINA NATURAL RESOURCES INC (0000793628) (Filer)

      5/27/25 4:30:02 PM ET
      $CHNR
      Precious Metals
      Basic Materials
    • SEC Form 424B5 filed by China Natural Resources Inc.

      424B5 - CHINA NATURAL RESOURCES INC (0000793628) (Filer)

      5/15/25 4:38:46 PM ET
      $CHNR
      Precious Metals
      Basic Materials

    $CHNR
    Financials

    Live finance-specific insights

    See more
    • China Natural Resources Reports Full Year 2022 Results

      HONG KONG, May 15, 2023 /PRNewswire/ -- China Natural Resources Inc. (NASDAQ:CHNR) (the "Company") today announced its results of operations for the year ended December 31, 2022. For the convenience of the reader, amounts in Chinese Yuan ("CNY") have been translated into United States dollars ("US$") at the rate of US$1.00 = CNY6.8979 as quoted by www.ofx.com on December 31, 2022, except as otherwise disclosed. Mr. Wong Wah On Edward, Chairman of the Company, commented, "We delivered over 8% annual revenue growth for the full year 2022, while reducing our net loss by 59%. Given the extremely challenging conditions we have been operating in, with supply chain closures and financing hurdles, w

      5/15/23 4:05:00 PM ET
      $CHNR
      Precious Metals
      Basic Materials

    $CHNR
    Leadership Updates

    Live Leadership Updates

    See more
    • China Natural Resources Appoints 20-year Pharmaceutical Executive Dr. Peng Wenlie as Vice President

      HONG KONG, March 23, 2021 /PRNewswire/ -- China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") announced today the appointment of pharmaceutical industry executive Peng Wenlie as Vice President, effective March 22, 2021.  Dr. Peng, who brings more than 20 years of experience working in the industry, will report directly to the Company's Chairman, Mr. Wong Wah On Edward.  He will be responsible for evaluating the Company's investment opportunities in the healthcare, biomedicine, and related markets. Mr. Wong Wah On Edward, Chairman of the Company, commented, "We are excited to announce the addition of Dr. Peng Wenlie as Vice President.  He shares our positive outlook for the extensive

      3/23/21 8:30:00 AM ET
      $CHNR
      Precious Metals
      Basic Materials

    $CHNR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by China Natural Resources Inc.

      SC 13G - CHINA NATURAL RESOURCES INC (0000793628) (Subject)

      11/14/24 5:24:39 PM ET
      $CHNR
      Precious Metals
      Basic Materials
    • SEC Form SC 13G filed by China Natural Resources Inc.

      SC 13G - CHINA NATURAL RESOURCES INC (0000793628) (Subject)

      7/26/22 4:06:30 PM ET
      $CHNR
      Precious Metals
      Basic Materials
    • SEC Form SC 13G filed by China Natural Resources Inc.

      SC 13G - CHINA NATURAL RESOURCES INC (0000793628) (Subject)

      7/26/22 4:05:51 PM ET
      $CHNR
      Precious Metals
      Basic Materials